Literature DB >> 32541897

Targeted protein degradation as a powerful research tool in basic biology and drug target discovery.

Tao Wu1,2, Hojong Yoon1,2, Yuan Xiong1,2, Sarah E Dixon-Clarke1,2, Radosław P Nowak1,2, Eric S Fischer3,4.   

Abstract

Controlled perturbation of protein activity is essential to study protein function in cells and living organisms. Small molecules that hijack the cellular protein ubiquitination machinery to selectively degrade proteins of interest, so-called degraders, have recently emerged as alternatives to selective chemical inhibitors, both as therapeutic modalities and as powerful research tools. These systems offer unprecedented temporal and spatial control over protein function. Here, we review recent developments in this field, with a particular focus on the use of degraders as research tools to interrogate complex biological problems.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32541897      PMCID: PMC7923177          DOI: 10.1038/s41594-020-0438-0

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  120 in total

Review 1.  Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting (Nobel lecture).

Authors:  Aaron Ciechanover
Journal:  Angew Chem Int Ed Engl       Date:  2005-09-19       Impact factor: 15.336

2.  Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates.

Authors:  R W King; M Glotzer; M W Kirschner
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

Review 3.  Ubiquitin Ligases: Structure, Function, and Regulation.

Authors:  Ning Zheng; Nitzan Shabek
Journal:  Annu Rev Biochem       Date:  2017-03-27       Impact factor: 23.643

Review 4.  Proteasomal and Autophagic Degradation Systems.

Authors:  Ivan Dikic
Journal:  Annu Rev Biochem       Date:  2017-05-01       Impact factor: 23.643

5.  A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.

Authors:  Laura A Banaszynski; Ling-Chun Chen; Lystranne A Maynard-Smith; A G Lisa Ooi; Thomas J Wandless
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

6.  A LOV2 domain-based optogenetic tool to control protein degradation and cellular function.

Authors:  Christian Renicke; Daniel Schuster; Svetlana Usherenko; Lars-Oliver Essen; Christof Taxis
Journal:  Chem Biol       Date:  2013-04-18

7.  Structural elements of the ubiquitin-independent proteasome degron of ornithine decarboxylase.

Authors:  Junko Takeuchi; Hui Chen; Martin A Hoyt; Philip Coffino
Journal:  Biochem J       Date:  2008-03-01       Impact factor: 3.857

8.  A strategy for the generation of conditional mutations by protein destabilization.

Authors:  E C Park; D Finley; J W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

9.  Tunable and reversible drug control of protein production via a self-excising degron.

Authors:  Hokyung K Chung; Conor L Jacobs; Yunwen Huo; Jin Yang; Stefanie A Krumm; Richard K Plemper; Roger Y Tsien; Michael Z Lin
Journal:  Nat Chem Biol       Date:  2015-07-27       Impact factor: 15.040

10.  Reversible Spatiotemporal Control of Induced Protein Degradation by Bistable PhotoPROTACs.

Authors:  Patrick Pfaff; Kusal T G Samarasinghe; Craig M Crews; Erick M Carreira
Journal:  ACS Cent Sci       Date:  2019-09-17       Impact factor: 14.553

View more
  32 in total

Review 1.  Drugging the "undruggable" microRNAs.

Authors:  Dejun Liu; Xinqiang Wan; Xiangxiang Shan; Rengen Fan; Wenzhang Zha
Journal:  Cell Mol Life Sci       Date:  2020-10-14       Impact factor: 9.261

2.  An "OFF-ON-OFF" fluorescence protein-labeling probe for real-time visualization of the degradation of short-lived proteins in cellular systems.

Authors:  Shahi Imam Reja; Yuichiro Hori; Takuya Kamikawa; Kohei Yamasaki; Miyako Nishiura; Steven D Bull; Kazuya Kikuchi
Journal:  Chem Sci       Date:  2022-01-11       Impact factor: 9.825

3.  RNA Pol II pausing facilitates phased pluripotency transitions by buffering transcription.

Authors:  Abderhman Abuhashem; Alexandra G Chivu; Yixin Zhao; Edward J Rice; Adam Siepel; Charles G Danko; Anna-Katerina Hadjantonakis
Journal:  Genes Dev       Date:  2022-08-18       Impact factor: 12.890

4.  Target-induced clustering activates Trim-Away of pathogens and proteins.

Authors:  Jingwei Zeng; Ana Filipa Santos; Aamir S Mukadam; Mariana Osswald; David A Jacques; Claire F Dickson; Stephen H McLaughlin; Christopher M Johnson; Leo Kiss; Jakub Luptak; Nadine Renner; Marina Vaysburd; William A McEwan; Eurico Morais-de-Sá; Dean Clift; Leo C James
Journal:  Nat Struct Mol Biol       Date:  2021-02-25       Impact factor: 15.369

Review 5.  The Regulation of RNA Modification Systems: The Next Frontier in Epitranscriptomics?

Authors:  Matthias R Schaefer
Journal:  Genes (Basel)       Date:  2021-02-26       Impact factor: 4.096

Review 6.  Targeting cell-cycle machinery in cancer.

Authors:  Jan M Suski; Marcin Braun; Vladislav Strmiska; Piotr Sicinski
Journal:  Cancer Cell       Date:  2021-04-22       Impact factor: 38.585

7.  Expression and purification of functional recombinant CUL2•RBX1 from E. coli.

Authors:  Stephanie Diaz; Lihong Li; Kankan Wang; Xing Liu
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

Review 8.  The Multifunctional Role of EMP3 in the Regulation of Membrane Receptors Associated with IDH-Wild-Type Glioblastoma.

Authors:  Antoni Andreu Martija; Stefan Pusch
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

9.  Hydrophobic Tagging-Mediated Degradation of Transcription Coactivator SRC-1.

Authors:  So Ra Choi; Hee Myeong Wang; Min Hyeon Shin; Hyun-Suk Lim
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

Review 10.  Controlling CRISPR with small molecule regulation for somatic cell genome editing.

Authors:  Namita Khajanchi; Krishanu Saha
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.